#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatobiliary cancer Chronic graft versus host disease in liver Epilepsy Ataxia telangiectasia Kearns-Sayre syndrome Hereditary spastic paraplegia Epilepsy with myoclonic-atonic seizures Anti-glomerular basement membrane disease Factor IX deficiency Glioblastoma Leiomyosarcoma White matter lesion Progressive multifocal leukoencephalopathy Carcinoid syndrome Kawasaki's disease More trials…

    Learn about Rare Diseases

    KBG syndrome – Treatment Nephrotic syndrome Richter’s syndrome – Life with Disease CADASIL – Diagnostics Nephrotic syndrome – Life with Disease Hairy cell leukaemia – Basic Information Hyperoxaluria – Basic Information Angiosarcoma – Diagnostics Piriformis syndrome – Trials in Disease Alveolar rhabdomyosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ibuprofen Sodium Dihydrate Pasireotide S227928 Clonidine Hydrochloride WEF-001 Balstilimab Gebasaxturev Minocycline Somapacitan Gilteritinib Ethambutol Datopotamab Deruxtecan Amikacin Atenolol Df6002 Haloperidol Decanoate Colchicine Enoxaparin Sodium Phenylephrine Hydrochloride Apocynin More therapies…

    Learn about Your Condition

    Thrombotic microangiopathy Medullary thyroid cancer Polycythaemia vera Breast cancer stage I Brain neoplasm malignant Breast proliferative changes Liposarcoma metastatic Melanoma recurrent Extraskeletal ossification Delayed graft function Lichenoid keratosis Colorectal cancer metastatic Gastrointestinal disorder Krabbe's disease Encephalopathy neonatal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Fakultna Nemocnica Trencín

Fakultna Nemocnica Trencín

Legionarska 28, Trencin, 911 01, Slovakia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Macular oedema
    • Retinal vein occlusion
    Investigated Drugs:
    • Fluorescein Sodium
    • Aflibercept
    Austria Bulgaria Czechia Estonia France Germany +8

  • Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Macular oedema
    • Diabetic retinal oedema
    Investigated Drugs:
    • Eye103
    • Fluorescein Sodium
    • Ranibizumab
    Austria Croatia Czechia France Germany Hungary +6
Previous Page
1 2 3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!